1Samuel Anaja Otene, 2Ransome Msughve Labe, 3Laadi Terrumun Swende, 4Perpetua Ngosoo Chia, 3Ohoizoje Bamidele Ornguga, 5Samuel Terkura Njor, 3Nndunno Asheku Akwaras, 3David Aondona Daniel, 3Iorfa Tor-Anyiin, 6Olayinka Benjamin Popoola, 7Oiza Tessy Ahmadu, 3Lawrence NP Dekaa, 8Grace N. Rimamnunra, 9Peteru Suega Inunduh, 8Grace Edem Atokolo, 8Joy Egbiri, 8Stella Ngusuur Haanongon
1Federal University of Health Science Otukpo, Benue State, Nigeria
2Department of Oncology and Palliative Care, Federal Medical Centre Makurdi, Benue State, Nigeria
3Department of Family Medicine, Federal Medical Centre Makurdi, Benue State, Nigeria
4Department of Clinical Psychology, Federal Medical Centre Makurdi, Benue State, Nigeria
5Worcester, United Kingdom
6Faculty of Allied Health Sciences, Baze University Abuja, Nigeria
7Oncology Department Federal Medical Centre, Abuja, Nigeria
8Department of Epidemiology and Community Medicine, College of Health Sciences, Benue State University Makurdi, Benue State, Nigeria
DOI : https://doi.org/10.47191/ijmra/v8-i03-56Google Scholar Download Pdf
ABSTRACT:
Introduction: Traditional medicine (TM) is a culturally adopted treatment method that is widely used without limitation to types of illnesses. Thus, even many patients diagnosed with cancer and referred for treatment at Oncology and Palliative Clinic in Federal Medical Centre Makurdi admitted using TM.
Objectives: This study examined the reasons that drive patients diagnosed with cancer’s preference for traditional medicine for the treatment of the disease.
Method: The study was a survey research design and 135 cancer patients responded to a self-developed questionnaire. The participants comprised of males 40(29.63%) and females 95(70.37%) with the age Mean = 51.16±10.87.
Results: The hypotheses tested showed that; many patients diagnosed with cancer have a significantly higher preference for the use of traditional medicine as a treatment alternative to their illness at χ2 (1, = 70) = 11.57f, p = 0.044. Many cancer patients did not have significantly positive belief that traditional medicine has effective potency to be used for treatment of cancer at χ2 (1, = 70) = 0.58, p = 0.445. Affordability, cultural belief, poverty, misinformation, family members persuasion, and lack of knowledge significantly influence many cancer patients’ preference for the use of traditional medicine at χ2 (1, = 70) = 2.29, p = 0.130.
Conclusion: The preference for TM undoubtedly contributes in part to patients’ delayed treatment and disease progression. Thus, it is pertinent for the government to collaborate with the healthcare professionals to adopt a community-based sensitization programme to discourage this disadvantageous health seeking behaviour.
Traditional medicine, Alternative treatment, Preference, Patients, Cancer.
REFERENCES1) Abdullahi, AA. Trends and challenges of traditional medicine in Africa. 2011. Available at: www.ncbi.nlm.nih.gov doi:10.4314/ajtmv8i5s.5
2) Adefolaju, T. The dynamics and changing structure of traditional healing system in Nigeria. Int J Health Res; 2011.4(2):99-106. Available at: https://www.ijhr.org
3) Neal, A. Traditional medicine, definition, history and examples. [update 3 July, 2023] Study.com. available at: https://study.com/academy/lesson/tradtional-medicine-definition-history-examples.html
4) World Health Organization. Traditional medicine has a long history of contribution to conventional medicine and still continues to hold promise. [2023] https://www.int
5) Kasil, OMJ, Wambebe C, Nikiema J-B, Nabyonga-Orem J. Towards universal health coverage: advancing the development and use of tradtional medicines in Africa. BMJ Global Health; 2019. 4: e001517. Doi:10.1136/bmjgh-2019-001517
6) World Health Organization. Traditional, complementary and integrative medicine. [2023] available at: www.who.int
7) Abbott R. Documenting Traditional Medical Knowledge. p.48, World Intellectual Property Organization, Geneva, Switzerland. [2014] to find its link http://www.wipo.int/tk/en/resources/publications.html
8) Chali BU, Hasho A, Koricha (n..b). Preference and Practice of Traditional Medicine and Associated Factors in Jimma Town, Southwest Ethiopia. Hindawi Evidence-Based Complementary and Alternative Medicine; 2021. Volume, Article ID 9962892, 7 pages available at: https://doi.org/10.1155/2021/9962892
9) International Agency for Research on Cancer (IARC, 2022-2023). World cancer report. Available at: https://www.iarc.who.int
10) Mwaka AD, Abbo C, Kinengyere AA. Traditional and complementary medicine use among adult cancer patients undergoing conventional treatment in Sub-Saharan Africa: A scoping review on the use, safety, and risks. Cancer Management and Research; 2020. Volume 2020: p: 3699-3712. Available at: DOI: https://doi.org./10.2147/CMAR.S251975
11) Jiofack T, Ayissi I. The role of turmeric in herbal medicinal for testicular damage. (2006). Chinenyes project-1.docx- HAPTER One 1.0… [uploaded by ChiefEaagle3889 on 3rd January, 2024] Available at: www.coursehero.com
12) International Union for Conservation of Nature. IUCN red list of threatened species. 2007. Available at: https://www.iucnredlist.org
13) Fokunang CN, Ndikum V, Tabi OY, Jiofack RB, Ngameni B, Guedje NM, TembeFokunang, EA, Tomkins P, Barkwan S, Kechia F, Asongalem E, Ngoupayou J, Torimiro NJ, Gonsu KH, Sielinou V, Ngadjui BT, Angwafor F, Nkongmeneck A, Abena OM, Ngogang J, Asonganyi T, Colizzi V, Lohoue J, Kamsu-Kom. Traditional medicine: past, present and future research and development prospects and integration in the national health system of Cameroon. Afr J Tradit Complement Altern Med. 2011. 8(3):284-295. www.ncbi.nlm.nih.gov
14) Li S, Odedina S, Agwai OO, Huo D, Olopade OI. Traditional medicine usage among adult women in Nigeria in Ibadan, Nigeria: across-study. BMC Complement Med Ther; 2020. Available at: 20:93 doi:10.1186/s12906-020-02881-z
15) Aina O, Gautam L, Simkhada P, Hall S. Prevalence of, determinants and knowledge about herbal medicine and non-hospital utilization is South-west Nigeria. BMJ Open; 2020.10(9) e040769. Available at: doi:10.1136/bmjopen-2020-040769
16) Damery S, Gratus C, Grieve R, Warmington S, Jones J, Routledge P, Greenfield S, Dowswell G, Sherriff J, Wilson S. The use of herbal medicines by people with cancer: a cross-sectional survey. British Journal of Cancer; 2011.104, 927–933. Vailable doi:10.1038/bjc.2011.47 www.bjcancer.com
17) Amorha KC, Nwabunike IA, Okwumuo BM, Ayogu EE, Nduka SO, Okonta MJ. Use of herbal medicines in a Nigerian community and their reported adverse effects: A pilot study. Tropical Journal of Pharmaceutical Research October; 2018.17 (10): 2067-2072 available at: http://www.tjpr.org http://dx.doi.org/10.4314/tjpr.v17i10.25
18) Ohemu TL, Sariem CN, Dafam DG, Ohemu BO, Okwori VA, Olotu PN, Jerome CO. Knowledge, Attitude and Practice of Traditional Medicine Among People of Jos North Local Government Area of Plateau State, Nigeria. International Journal of Pharmacognosy and Phytochemical Research; 2017. 9(10); 1353-1358 available at: www.ijppr.com doi: 10.25258/phyto.v9i10.10460
19) James PB, Wardle J, Steel A, Adams J. Traditional, complementary and alternative medicine use in Sub-Saharan Africa: a systematic review. BMJ Glob Health; 2018. 3: e000895. Available at: doi:10.1136/ bmjgh-2018-000895
20) Asiimwe BJ, Nagendrappa PB, Atukunda EC, Kamatenesi MM, Nambozi G, Tolo CU, Ogwang PE, Sarki AM. Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine, (2021). Article 9963038. https://doi.org/10.1155/2021/9963038
21) Aboufaras M, Selmaoui K, Raja N, Lakhdissim A, Ouzennou N. Predictors of herbal medicine use among cancer patients. Research Square; 2022, 7-29. Available at: https://doi.org/10.21203/rs.3.rs-2112180/v1
22) Ezeoma ER, Anarado AN. Use of complementary alternative medicine by cancer patients at the University of Nigeria Teaching Hospital Enugu, Nigeria. BMC Complementary and Altern Med 7; 28(2007). Available at: https://doi.org/10.1186/1472-6882-7-28
23) Tavakoli J, Miar S, Zandehzare MM, Akban H. Evaluation of effectiveness of herbal medication in cancer care: a review study. Iran J cancer Prev; 2012. 5(3): 144-156. Available at: www.ncbi.nlm.nih.gov
24) Cancer Research UK (n.d.). Herbal medicine and cancer. Available at: www.cancerresearchuk.org
25) Herbal medicine for Mesothioloma and other cancers (2024). Available at: www.mesothiolomahub.com
26) Thomas TH. What are the most curable cancers? [Updated on March 3, 2023]. Available at: https://www,medicalnewstoday.com
27) Robinson, J. (2023). Curable cancers. https://www.webmd.com
28) Iyiola AO, Adegoke MKW 2023. Herbal medicine methods and practices in Nigeria. In: Izah SC, Ogwu MC, Akram M (eds). Herbal medicine phytochemistry. Available at: https://doi.org/10.1007/978-3-031-21973_47-1
29) Cancer Research UK. Types of cancers. [9 October, 2023]. Available at: https://www.cancerresearchuk.org
30) International Agency for Research on Cancer (IARC, 2022-2023). World cancer report. Available at: https://www.iarc.who.int
31) Nigeria National Cancer Control Plan [NCCP]. 2018-2022. Available at: https://www,iccp-portal.org
32) Chow Z, Gan T, Chen Q, Huang B, Schoenberg N, Dignan M… Bhakta A. S. Nonadherence to standard of care for locally advanced colon cancer as a contributory factor for high mortality rates in Kentucky. J A Coll Sur; 2020. 230(4), 428-439. Doi: 10.1016/j.amcollsurg.2019.12.041
33) Dronkers EA, Mes SW, Wieringa MH, van der Schroeff MP, Baatenburg de Jong RJ (2015). Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician. BMC cancer 15;(2015). Available at: https://doi.org/10.1186/s12885-015-1523-3
34) Eom BW, Jung KW, Won YJ, Kim YW. Trends and Outcomes of Noncompliance with Treatment for Gastric Cancer in Korea over the 16 years from 1999 to 2015. Journal of Gastric Cancer; 2019.Mar; 19(1): 92.101. Doi: 10.5230/jgc. 2019.e5. Epub2019 Feb20. PMID: 30944762; PMCID: PMC6441768
35) Borras JM, Font R, Solà J, Macia M, Tuset V, Arenas M, ... Espinàs JA. Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in Catalonia, Spain. Radiotherapy and Oncology; 2020. 151, 200205. Available at: https://doi.org/10.1016/j.radonc.2020.08.002
36) Hansen LA. Impact of nonadherence to cancer therapy. TON The Oncology NurseAPNPA; 2024. 3(1); 14-15 available at: https://www.theoncologynurse.com
37) 38. Otene SA, Labe RM, Swende LT, Njor ST, Popoola OB. Noncompliance to Standard Treatment Procedures for Cancer Propelling Increase in the Mortality Rate of Cancer Patients in Benue State, Nigeria. Cancer Research and Cell Development; 2024. 3(1). Available at: Doi: https://doi.org
38) Vives L. In Nigeria, 72000 cancer death annually and rising. IDN-IndepthNews; 2022-10-24 Available at: https://indepthnews.net
Volume 08 Issue 03 March 2025
There is an Open Access article, distributed under the term of the Creative Commons Attribution – Non Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting and building upon the work for non-commercial use, provided the original work is properly cited.
Our Services and Policies
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.
The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.
International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.
Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.
International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 08 Issue 04 (April 2025).
PUBLICATION DATES:
1) Last Date of Submission : 26 April 2025.
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online
Why with us
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.
The Editors reserve the right to reject papers without sending them out for review.
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.